Hypertension: CVRx wins FDA nod for Barostim neo legacy

The FDA grants a humanitarian device exemption for CVRx's Barostim neo legacy device for treating drug-resistant hypertension.

CVRx said yesterday that it won a humanitarian device exemption from the FDA for its Barostim neo legacy device, to treat drug-resistant hypertension.

CVRx Inc., Food & Drug Administration (FDA)

News Well, Humanitarian Device Exemption (HDE), Hypertension, Neuromodulation/Neurostimulation, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BYdDEr